Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany
الحاوية / القاعدة: | Journal of Critical Care 66(2021)S. 187-188 |
---|---|
المؤلفون الرئيسيون: | Köhler, Thomas (مؤلف), Schwier, Elke (مؤلف), Henzler, Dietrich (مؤلف), Eickmeyer, Claas (مؤلف) |
التنسيق: | مقال |
اللغة: | English |
منشور في: |
2021
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1016/j.jcrc.2021.07.011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314144/ |
مواد ذات صلة: | In:
Journal of Critical Care |
مواد مشابهة
-
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
بواسطة: Schultz, Philipp, وآخرون
منشور في: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
بواسطة: Hawchar, Fatime, وآخرون
منشور في: (2022) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
بواسطة: Köhler, Thomas, وآخرون
منشور في: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
بواسطة: Köhler, Thomas, وآخرون
منشور في: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
بواسطة: Unterberg, Matthias, وآخرون
منشور في: (2022)